nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2D6—Vinorelbine—ovarian cancer	0.0455	0.212	CbGbCtD
Ropivacaine—CYP3A4—Topotecan—ovarian cancer	0.0411	0.192	CbGbCtD
Ropivacaine—CYP2B6—Doxorubicin—ovarian cancer	0.0357	0.166	CbGbCtD
Ropivacaine—CYP3A4—Vinorelbine—ovarian cancer	0.029	0.135	CbGbCtD
Ropivacaine—CYP3A4—Paclitaxel—ovarian cancer	0.0203	0.0948	CbGbCtD
Ropivacaine—CYP2D6—Doxorubicin—ovarian cancer	0.0172	0.0803	CbGbCtD
Ropivacaine—CYP3A4—Docetaxel—ovarian cancer	0.0147	0.0685	CbGbCtD
Ropivacaine—CYP3A4—Doxorubicin—ovarian cancer	0.011	0.0511	CbGbCtD
Ropivacaine—Lidocaine—EGFR—ovarian cancer	0.00279	0.767	CrCbGaD
Ropivacaine—Lidocaine—ABCB1—ovarian cancer	0.000847	0.233	CrCbGaD
Ropivacaine—Arrhythmia—Docetaxel—ovarian cancer	0.000639	0.000833	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000637	0.00083	CcSEcCtD
Ropivacaine—Convulsion—Paclitaxel—ovarian cancer	0.000636	0.00083	CcSEcCtD
Ropivacaine—Affect lability—Doxorubicin—ovarian cancer	0.000635	0.000828	CcSEcCtD
Ropivacaine—Hypokalaemia—Epirubicin—ovarian cancer	0.000635	0.000827	CcSEcCtD
Ropivacaine—Hypertension—Paclitaxel—ovarian cancer	0.000634	0.000827	CcSEcCtD
Ropivacaine—Pruritus—Vinorelbine—ovarian cancer	0.00063	0.000822	CcSEcCtD
Ropivacaine—Breast disorder—Epirubicin—ovarian cancer	0.00063	0.000822	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000628	0.000819	CcSEcCtD
Ropivacaine—Mental disorder—Docetaxel—ovarian cancer	0.000626	0.000817	CcSEcCtD
Ropivacaine—Arthralgia—Paclitaxel—ovarian cancer	0.000625	0.000815	CcSEcCtD
Ropivacaine—Myalgia—Paclitaxel—ovarian cancer	0.000625	0.000815	CcSEcCtD
Ropivacaine—Chest pain—Paclitaxel—ovarian cancer	0.000625	0.000815	CcSEcCtD
Ropivacaine—Anxiety—Paclitaxel—ovarian cancer	0.000623	0.000812	CcSEcCtD
Ropivacaine—Erythema—Docetaxel—ovarian cancer	0.000622	0.000812	CcSEcCtD
Ropivacaine—Nausea—Topotecan—ovarian cancer	0.000619	0.000807	CcSEcCtD
Ropivacaine—Discomfort—Paclitaxel—ovarian cancer	0.000618	0.000806	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000615	0.000802	CcSEcCtD
Ropivacaine—Cardiac arrest—Doxorubicin—ovarian cancer	0.000613	0.0008	CcSEcCtD
Ropivacaine—Mood swings—Doxorubicin—ovarian cancer	0.000611	0.000797	CcSEcCtD
Ropivacaine—Diarrhoea—Vinorelbine—ovarian cancer	0.00061	0.000795	CcSEcCtD
Ropivacaine—Abdominal distension—Epirubicin—ovarian cancer	0.000607	0.000791	CcSEcCtD
Ropivacaine—Nausea—Melphalan—ovarian cancer	0.000606	0.00079	CcSEcCtD
Ropivacaine—Confusional state—Paclitaxel—ovarian cancer	0.000604	0.000788	CcSEcCtD
Ropivacaine—Back pain—Docetaxel—ovarian cancer	0.000602	0.000785	CcSEcCtD
Ropivacaine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000599	0.000782	CcSEcCtD
Ropivacaine—Muscle spasms—Docetaxel—ovarian cancer	0.000598	0.00078	CcSEcCtD
Ropivacaine—Infection—Paclitaxel—ovarian cancer	0.000595	0.000776	CcSEcCtD
Ropivacaine—Shock—Paclitaxel—ovarian cancer	0.00059	0.000769	CcSEcCtD
Ropivacaine—Dizziness—Vinorelbine—ovarian cancer	0.000589	0.000768	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000589	0.000768	CcSEcCtD
Ropivacaine—Hypokalaemia—Doxorubicin—ovarian cancer	0.000587	0.000766	CcSEcCtD
Ropivacaine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000587	0.000765	CcSEcCtD
Ropivacaine—Tachycardia—Paclitaxel—ovarian cancer	0.000585	0.000763	CcSEcCtD
Ropivacaine—Breast disorder—Doxorubicin—ovarian cancer	0.000583	0.00076	CcSEcCtD
Ropivacaine—Skin disorder—Paclitaxel—ovarian cancer	0.000582	0.000759	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000581	0.000757	CcSEcCtD
Ropivacaine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000579	0.000756	CcSEcCtD
Ropivacaine—Anaemia—Docetaxel—ovarian cancer	0.000575	0.00075	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000569	0.000742	CcSEcCtD
Ropivacaine—Vomiting—Vinorelbine—ovarian cancer	0.000567	0.000739	CcSEcCtD
Ropivacaine—Dysuria—Epirubicin—ovarian cancer	0.000563	0.000735	CcSEcCtD
Ropivacaine—Rash—Vinorelbine—ovarian cancer	0.000562	0.000733	CcSEcCtD
Ropivacaine—Dermatitis—Vinorelbine—ovarian cancer	0.000561	0.000732	CcSEcCtD
Ropivacaine—Abdominal distension—Doxorubicin—ovarian cancer	0.000561	0.000732	CcSEcCtD
Ropivacaine—Hypotension—Paclitaxel—ovarian cancer	0.00056	0.00073	CcSEcCtD
Ropivacaine—Headache—Vinorelbine—ovarian cancer	0.000558	0.000728	CcSEcCtD
Ropivacaine—Syncope—Docetaxel—ovarian cancer	0.000558	0.000728	CcSEcCtD
Ropivacaine—Loss of consciousness—Docetaxel—ovarian cancer	0.000547	0.000713	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000546	0.000712	CcSEcCtD
Ropivacaine—Hyperglycaemia—Epirubicin—ovarian cancer	0.000544	0.000709	CcSEcCtD
Ropivacaine—Cough—Docetaxel—ovarian cancer	0.000543	0.000708	CcSEcCtD
Ropivacaine—Insomnia—Paclitaxel—ovarian cancer	0.000542	0.000707	CcSEcCtD
Ropivacaine—Convulsion—Docetaxel—ovarian cancer	0.000539	0.000703	CcSEcCtD
Ropivacaine—Paraesthesia—Paclitaxel—ovarian cancer	0.000538	0.000702	CcSEcCtD
Ropivacaine—Hypertension—Docetaxel—ovarian cancer	0.000537	0.000701	CcSEcCtD
Ropivacaine—Drowsiness—Epirubicin—ovarian cancer	0.000537	0.000701	CcSEcCtD
Ropivacaine—Dyspnoea—Paclitaxel—ovarian cancer	0.000534	0.000697	CcSEcCtD
Ropivacaine—Somnolence—Paclitaxel—ovarian cancer	0.000533	0.000695	CcSEcCtD
Ropivacaine—Chest pain—Docetaxel—ovarian cancer	0.00053	0.000691	CcSEcCtD
Ropivacaine—Arthralgia—Docetaxel—ovarian cancer	0.00053	0.000691	CcSEcCtD
Ropivacaine—Myalgia—Docetaxel—ovarian cancer	0.00053	0.000691	CcSEcCtD
Ropivacaine—Nausea—Vinorelbine—ovarian cancer	0.000529	0.00069	CcSEcCtD
Ropivacaine—Dyspepsia—Paclitaxel—ovarian cancer	0.000528	0.000688	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000527	0.000687	CcSEcCtD
Ropivacaine—Jaundice—Epirubicin—ovarian cancer	0.000524	0.000683	CcSEcCtD
Ropivacaine—Urinary tract infection—Epirubicin—ovarian cancer	0.000522	0.000681	CcSEcCtD
Ropivacaine—Dysuria—Doxorubicin—ovarian cancer	0.000521	0.00068	CcSEcCtD
Ropivacaine—Constipation—Paclitaxel—ovarian cancer	0.000513	0.000668	CcSEcCtD
Ropivacaine—Pain—Paclitaxel—ovarian cancer	0.000513	0.000668	CcSEcCtD
Ropivacaine—Haematuria—Epirubicin—ovarian cancer	0.000512	0.000668	CcSEcCtD
Ropivacaine—Confusional state—Docetaxel—ovarian cancer	0.000512	0.000668	CcSEcCtD
Ropivacaine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000508	0.000662	CcSEcCtD
Ropivacaine—Infection—Docetaxel—ovarian cancer	0.000505	0.000658	CcSEcCtD
Ropivacaine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000503	0.000656	CcSEcCtD
Ropivacaine—Shock—Docetaxel—ovarian cancer	0.0005	0.000652	CcSEcCtD
Ropivacaine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000497	0.000649	CcSEcCtD
Ropivacaine—Drowsiness—Doxorubicin—ovarian cancer	0.000497	0.000648	CcSEcCtD
Ropivacaine—Tachycardia—Docetaxel—ovarian cancer	0.000496	0.000647	CcSEcCtD
Ropivacaine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000494	0.000644	CcSEcCtD
Ropivacaine—Skin disorder—Docetaxel—ovarian cancer	0.000493	0.000643	CcSEcCtD
Ropivacaine—Bradycardia—Epirubicin—ovarian cancer	0.000491	0.00064	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00049	0.000639	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000487	0.000635	CcSEcCtD
Ropivacaine—Jaundice—Doxorubicin—ovarian cancer	0.000485	0.000632	CcSEcCtD
Ropivacaine—Rhinitis—Epirubicin—ovarian cancer	0.000484	0.000631	CcSEcCtD
Ropivacaine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000483	0.00063	CcSEcCtD
Ropivacaine—Hypoaesthesia—Epirubicin—ovarian cancer	0.00048	0.000626	CcSEcCtD
Ropivacaine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000476	0.000621	CcSEcCtD
Ropivacaine—Urticaria—Paclitaxel—ovarian cancer	0.000476	0.000621	CcSEcCtD
Ropivacaine—Oedema peripheral—Epirubicin—ovarian cancer	0.000475	0.00062	CcSEcCtD
Ropivacaine—Hypotension—Docetaxel—ovarian cancer	0.000475	0.000619	CcSEcCtD
Ropivacaine—Haematuria—Doxorubicin—ovarian cancer	0.000474	0.000618	CcSEcCtD
Ropivacaine—Abdominal pain—Paclitaxel—ovarian cancer	0.000474	0.000618	CcSEcCtD
Ropivacaine—Body temperature increased—Paclitaxel—ovarian cancer	0.000474	0.000618	CcSEcCtD
Ropivacaine—Urethral disorder—Epirubicin—ovarian cancer	0.000473	0.000617	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000463	0.000604	CcSEcCtD
Ropivacaine—Insomnia—Docetaxel—ovarian cancer	0.000459	0.000599	CcSEcCtD
Ropivacaine—Paraesthesia—Docetaxel—ovarian cancer	0.000456	0.000595	CcSEcCtD
Ropivacaine—Bradycardia—Doxorubicin—ovarian cancer	0.000454	0.000592	CcSEcCtD
Ropivacaine—Dyspnoea—Docetaxel—ovarian cancer	0.000453	0.000591	CcSEcCtD
Ropivacaine—Somnolence—Docetaxel—ovarian cancer	0.000452	0.000589	CcSEcCtD
Ropivacaine—Tinnitus—Epirubicin—ovarian cancer	0.00045	0.000586	CcSEcCtD
Ropivacaine—Cardiac disorder—Epirubicin—ovarian cancer	0.000448	0.000584	CcSEcCtD
Ropivacaine—Rhinitis—Doxorubicin—ovarian cancer	0.000447	0.000583	CcSEcCtD
Ropivacaine—Dyspepsia—Docetaxel—ovarian cancer	0.000447	0.000583	CcSEcCtD
Ropivacaine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000444	0.000579	CcSEcCtD
Ropivacaine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000442	0.000576	CcSEcCtD
Ropivacaine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000441	0.000575	CcSEcCtD
Ropivacaine—Oedema peripheral—Doxorubicin—ovarian cancer	0.00044	0.000573	CcSEcCtD
Ropivacaine—Urethral disorder—Doxorubicin—ovarian cancer	0.000437	0.00057	CcSEcCtD
Ropivacaine—Constipation—Docetaxel—ovarian cancer	0.000434	0.000567	CcSEcCtD
Ropivacaine—Pain—Docetaxel—ovarian cancer	0.000434	0.000567	CcSEcCtD
Ropivacaine—Chills—Epirubicin—ovarian cancer	0.000433	0.000564	CcSEcCtD
Ropivacaine—Arrhythmia—Epirubicin—ovarian cancer	0.000431	0.000562	CcSEcCtD
Ropivacaine—Asthenia—Paclitaxel—ovarian cancer	0.00043	0.000561	CcSEcCtD
Ropivacaine—Pruritus—Paclitaxel—ovarian cancer	0.000424	0.000553	CcSEcCtD
Ropivacaine—Mental disorder—Epirubicin—ovarian cancer	0.000423	0.000551	CcSEcCtD
Ropivacaine—Erythema—Epirubicin—ovarian cancer	0.00042	0.000547	CcSEcCtD
Ropivacaine—Feeling abnormal—Docetaxel—ovarian cancer	0.000419	0.000546	CcSEcCtD
Ropivacaine—Tinnitus—Doxorubicin—ovarian cancer	0.000416	0.000543	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000415	0.000542	CcSEcCtD
Ropivacaine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000414	0.00054	CcSEcCtD
Ropivacaine—Tension—Epirubicin—ovarian cancer	0.000412	0.000537	CcSEcCtD
Ropivacaine—Diarrhoea—Paclitaxel—ovarian cancer	0.00041	0.000535	CcSEcCtD
Ropivacaine—Nervousness—Epirubicin—ovarian cancer	0.000408	0.000532	CcSEcCtD
Ropivacaine—Back pain—Epirubicin—ovarian cancer	0.000406	0.00053	CcSEcCtD
Ropivacaine—Muscle spasms—Epirubicin—ovarian cancer	0.000404	0.000526	CcSEcCtD
Ropivacaine—Abdominal pain—Docetaxel—ovarian cancer	0.000402	0.000524	CcSEcCtD
Ropivacaine—Body temperature increased—Docetaxel—ovarian cancer	0.000402	0.000524	CcSEcCtD
Ropivacaine—Chills—Doxorubicin—ovarian cancer	0.0004	0.000522	CcSEcCtD
Ropivacaine—Arrhythmia—Doxorubicin—ovarian cancer	0.000399	0.00052	CcSEcCtD
Ropivacaine—Dizziness—Paclitaxel—ovarian cancer	0.000396	0.000517	CcSEcCtD
Ropivacaine—Vision blurred—Epirubicin—ovarian cancer	0.000396	0.000516	CcSEcCtD
Ropivacaine—Mental disorder—Doxorubicin—ovarian cancer	0.000391	0.00051	CcSEcCtD
Ropivacaine—Ill-defined disorder—Epirubicin—ovarian cancer	0.00039	0.000508	CcSEcCtD
Ropivacaine—Erythema—Doxorubicin—ovarian cancer	0.000388	0.000507	CcSEcCtD
Ropivacaine—Anaemia—Epirubicin—ovarian cancer	0.000388	0.000506	CcSEcCtD
Ropivacaine—Agitation—Epirubicin—ovarian cancer	0.000386	0.000503	CcSEcCtD
Ropivacaine—Tension—Doxorubicin—ovarian cancer	0.000381	0.000497	CcSEcCtD
Ropivacaine—Vomiting—Paclitaxel—ovarian cancer	0.000381	0.000497	CcSEcCtD
Ropivacaine—Malaise—Epirubicin—ovarian cancer	0.000379	0.000494	CcSEcCtD
Ropivacaine—Rash—Paclitaxel—ovarian cancer	0.000378	0.000493	CcSEcCtD
Ropivacaine—Dermatitis—Paclitaxel—ovarian cancer	0.000378	0.000492	CcSEcCtD
Ropivacaine—Nervousness—Doxorubicin—ovarian cancer	0.000377	0.000492	CcSEcCtD
Ropivacaine—Vertigo—Epirubicin—ovarian cancer	0.000377	0.000492	CcSEcCtD
Ropivacaine—Syncope—Epirubicin—ovarian cancer	0.000377	0.000491	CcSEcCtD
Ropivacaine—Back pain—Doxorubicin—ovarian cancer	0.000376	0.00049	CcSEcCtD
Ropivacaine—Headache—Paclitaxel—ovarian cancer	0.000375	0.00049	CcSEcCtD
Ropivacaine—Hypersensitivity—Docetaxel—ovarian cancer	0.000374	0.000488	CcSEcCtD
Ropivacaine—Muscle spasms—Doxorubicin—ovarian cancer	0.000374	0.000487	CcSEcCtD
Ropivacaine—Loss of consciousness—Epirubicin—ovarian cancer	0.000369	0.000481	CcSEcCtD
Ropivacaine—Cough—Epirubicin—ovarian cancer	0.000366	0.000478	CcSEcCtD
Ropivacaine—Vision blurred—Doxorubicin—ovarian cancer	0.000366	0.000477	CcSEcCtD
Ropivacaine—Asthenia—Docetaxel—ovarian cancer	0.000365	0.000475	CcSEcCtD
Ropivacaine—Convulsion—Epirubicin—ovarian cancer	0.000364	0.000474	CcSEcCtD
Ropivacaine—Hypertension—Epirubicin—ovarian cancer	0.000362	0.000473	CcSEcCtD
Ropivacaine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00036	0.00047	CcSEcCtD
Ropivacaine—Pruritus—Docetaxel—ovarian cancer	0.000359	0.000469	CcSEcCtD
Ropivacaine—Anaemia—Doxorubicin—ovarian cancer	0.000359	0.000468	CcSEcCtD
Ropivacaine—Arthralgia—Epirubicin—ovarian cancer	0.000357	0.000466	CcSEcCtD
Ropivacaine—Myalgia—Epirubicin—ovarian cancer	0.000357	0.000466	CcSEcCtD
Ropivacaine—Chest pain—Epirubicin—ovarian cancer	0.000357	0.000466	CcSEcCtD
Ropivacaine—Agitation—Doxorubicin—ovarian cancer	0.000357	0.000466	CcSEcCtD
Ropivacaine—Anxiety—Epirubicin—ovarian cancer	0.000356	0.000465	CcSEcCtD
Ropivacaine—Nausea—Paclitaxel—ovarian cancer	0.000356	0.000464	CcSEcCtD
Ropivacaine—Discomfort—Epirubicin—ovarian cancer	0.000353	0.000461	CcSEcCtD
Ropivacaine—Malaise—Doxorubicin—ovarian cancer	0.00035	0.000457	CcSEcCtD
Ropivacaine—Vertigo—Doxorubicin—ovarian cancer	0.000349	0.000455	CcSEcCtD
Ropivacaine—Syncope—Doxorubicin—ovarian cancer	0.000348	0.000454	CcSEcCtD
Ropivacaine—Diarrhoea—Docetaxel—ovarian cancer	0.000348	0.000453	CcSEcCtD
Ropivacaine—Confusional state—Epirubicin—ovarian cancer	0.000346	0.000451	CcSEcCtD
Ropivacaine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000343	0.000447	CcSEcCtD
Ropivacaine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000341	0.000445	CcSEcCtD
Ropivacaine—Infection—Epirubicin—ovarian cancer	0.00034	0.000444	CcSEcCtD
Ropivacaine—Cough—Doxorubicin—ovarian cancer	0.000339	0.000442	CcSEcCtD
Ropivacaine—Shock—Epirubicin—ovarian cancer	0.000337	0.00044	CcSEcCtD
Ropivacaine—Convulsion—Doxorubicin—ovarian cancer	0.000337	0.000439	CcSEcCtD
Ropivacaine—Dizziness—Docetaxel—ovarian cancer	0.000336	0.000438	CcSEcCtD
Ropivacaine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000336	0.000437	CcSEcCtD
Ropivacaine—Hypertension—Doxorubicin—ovarian cancer	0.000335	0.000437	CcSEcCtD
Ropivacaine—Tachycardia—Epirubicin—ovarian cancer	0.000334	0.000436	CcSEcCtD
Ropivacaine—Skin disorder—Epirubicin—ovarian cancer	0.000333	0.000434	CcSEcCtD
Ropivacaine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000331	0.000432	CcSEcCtD
Ropivacaine—Arthralgia—Doxorubicin—ovarian cancer	0.000331	0.000431	CcSEcCtD
Ropivacaine—Chest pain—Doxorubicin—ovarian cancer	0.000331	0.000431	CcSEcCtD
Ropivacaine—Myalgia—Doxorubicin—ovarian cancer	0.000331	0.000431	CcSEcCtD
Ropivacaine—Anxiety—Doxorubicin—ovarian cancer	0.00033	0.00043	CcSEcCtD
Ropivacaine—Discomfort—Doxorubicin—ovarian cancer	0.000327	0.000426	CcSEcCtD
Ropivacaine—Vomiting—Docetaxel—ovarian cancer	0.000323	0.000421	CcSEcCtD
Ropivacaine—Rash—Docetaxel—ovarian cancer	0.00032	0.000418	CcSEcCtD
Ropivacaine—Hypotension—Epirubicin—ovarian cancer	0.00032	0.000418	CcSEcCtD
Ropivacaine—Dermatitis—Docetaxel—ovarian cancer	0.00032	0.000417	CcSEcCtD
Ropivacaine—Confusional state—Doxorubicin—ovarian cancer	0.00032	0.000417	CcSEcCtD
Ropivacaine—Headache—Docetaxel—ovarian cancer	0.000318	0.000415	CcSEcCtD
Ropivacaine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000317	0.000413	CcSEcCtD
Ropivacaine—Infection—Doxorubicin—ovarian cancer	0.000315	0.000411	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000312	0.000407	CcSEcCtD
Ropivacaine—Shock—Doxorubicin—ovarian cancer	0.000312	0.000407	CcSEcCtD
Ropivacaine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00031	0.000405	CcSEcCtD
Ropivacaine—Insomnia—Epirubicin—ovarian cancer	0.00031	0.000404	CcSEcCtD
Ropivacaine—Tachycardia—Doxorubicin—ovarian cancer	0.000309	0.000404	CcSEcCtD
Ropivacaine—Skin disorder—Doxorubicin—ovarian cancer	0.000308	0.000402	CcSEcCtD
Ropivacaine—Paraesthesia—Epirubicin—ovarian cancer	0.000308	0.000401	CcSEcCtD
Ropivacaine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000307	0.0004	CcSEcCtD
Ropivacaine—Dyspnoea—Epirubicin—ovarian cancer	0.000306	0.000398	CcSEcCtD
Ropivacaine—Somnolence—Epirubicin—ovarian cancer	0.000305	0.000397	CcSEcCtD
Ropivacaine—Nausea—Docetaxel—ovarian cancer	0.000302	0.000393	CcSEcCtD
Ropivacaine—Dyspepsia—Epirubicin—ovarian cancer	0.000302	0.000393	CcSEcCtD
Ropivacaine—Hypotension—Doxorubicin—ovarian cancer	0.000296	0.000386	CcSEcCtD
Ropivacaine—Constipation—Epirubicin—ovarian cancer	0.000293	0.000382	CcSEcCtD
Ropivacaine—Pain—Epirubicin—ovarian cancer	0.000293	0.000382	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000289	0.000377	CcSEcCtD
Ropivacaine—Insomnia—Doxorubicin—ovarian cancer	0.000287	0.000374	CcSEcCtD
Ropivacaine—Paraesthesia—Doxorubicin—ovarian cancer	0.000285	0.000371	CcSEcCtD
Ropivacaine—Dyspnoea—Doxorubicin—ovarian cancer	0.000283	0.000369	CcSEcCtD
Ropivacaine—Feeling abnormal—Epirubicin—ovarian cancer	0.000282	0.000368	CcSEcCtD
Ropivacaine—Somnolence—Doxorubicin—ovarian cancer	0.000282	0.000368	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00028	0.000365	CcSEcCtD
Ropivacaine—Dyspepsia—Doxorubicin—ovarian cancer	0.000279	0.000364	CcSEcCtD
Ropivacaine—Urticaria—Epirubicin—ovarian cancer	0.000272	0.000355	CcSEcCtD
Ropivacaine—Pain—Doxorubicin—ovarian cancer	0.000271	0.000354	CcSEcCtD
Ropivacaine—Constipation—Doxorubicin—ovarian cancer	0.000271	0.000354	CcSEcCtD
Ropivacaine—Abdominal pain—Epirubicin—ovarian cancer	0.000271	0.000353	CcSEcCtD
Ropivacaine—Body temperature increased—Epirubicin—ovarian cancer	0.000271	0.000353	CcSEcCtD
Ropivacaine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000261	0.000341	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000259	0.000338	CcSEcCtD
Ropivacaine—Hypersensitivity—Epirubicin—ovarian cancer	0.000252	0.000329	CcSEcCtD
Ropivacaine—Urticaria—Doxorubicin—ovarian cancer	0.000252	0.000328	CcSEcCtD
Ropivacaine—Body temperature increased—Doxorubicin—ovarian cancer	0.000251	0.000327	CcSEcCtD
Ropivacaine—Abdominal pain—Doxorubicin—ovarian cancer	0.000251	0.000327	CcSEcCtD
Ropivacaine—Asthenia—Epirubicin—ovarian cancer	0.000246	0.000321	CcSEcCtD
Ropivacaine—Pruritus—Epirubicin—ovarian cancer	0.000242	0.000316	CcSEcCtD
Ropivacaine—Diarrhoea—Epirubicin—ovarian cancer	0.000234	0.000306	CcSEcCtD
Ropivacaine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000234	0.000305	CcSEcCtD
Ropivacaine—Asthenia—Doxorubicin—ovarian cancer	0.000227	0.000297	CcSEcCtD
Ropivacaine—Dizziness—Epirubicin—ovarian cancer	0.000227	0.000295	CcSEcCtD
Ropivacaine—Pruritus—Doxorubicin—ovarian cancer	0.000224	0.000293	CcSEcCtD
Ropivacaine—Vomiting—Epirubicin—ovarian cancer	0.000218	0.000284	CcSEcCtD
Ropivacaine—Diarrhoea—Doxorubicin—ovarian cancer	0.000217	0.000283	CcSEcCtD
Ropivacaine—Rash—Epirubicin—ovarian cancer	0.000216	0.000282	CcSEcCtD
Ropivacaine—Dermatitis—Epirubicin—ovarian cancer	0.000216	0.000281	CcSEcCtD
Ropivacaine—Headache—Epirubicin—ovarian cancer	0.000215	0.00028	CcSEcCtD
Ropivacaine—Dizziness—Doxorubicin—ovarian cancer	0.00021	0.000273	CcSEcCtD
Ropivacaine—Nausea—Epirubicin—ovarian cancer	0.000204	0.000265	CcSEcCtD
Ropivacaine—Vomiting—Doxorubicin—ovarian cancer	0.000202	0.000263	CcSEcCtD
Ropivacaine—Rash—Doxorubicin—ovarian cancer	0.0002	0.000261	CcSEcCtD
Ropivacaine—Dermatitis—Doxorubicin—ovarian cancer	0.0002	0.00026	CcSEcCtD
Ropivacaine—Headache—Doxorubicin—ovarian cancer	0.000199	0.000259	CcSEcCtD
Ropivacaine—Nausea—Doxorubicin—ovarian cancer	0.000188	0.000246	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—HRAS—ovarian cancer	2.58e-05	0.00173	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—ERBB2—ovarian cancer	2.56e-05	0.00172	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—VEGFA—ovarian cancer	2.56e-05	0.00172	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—VEGFA—ovarian cancer	2.56e-05	0.00172	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—VEGFA—ovarian cancer	2.55e-05	0.00171	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—NRAS—ovarian cancer	2.53e-05	0.0017	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—NRAS—ovarian cancer	2.53e-05	0.0017	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—STAT3—ovarian cancer	2.52e-05	0.0017	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—NRAS—ovarian cancer	2.52e-05	0.00169	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MAPK3—ovarian cancer	2.51e-05	0.00169	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—MAPK3—ovarian cancer	2.51e-05	0.00169	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—MAPK1—ovarian cancer	2.49e-05	0.00167	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—EGFR—ovarian cancer	2.48e-05	0.00167	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—IL6—ovarian cancer	2.47e-05	0.00166	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—ERBB2—ovarian cancer	2.46e-05	0.00165	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—ERBB2—ovarian cancer	2.46e-05	0.00165	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—KRAS—ovarian cancer	2.45e-05	0.00165	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MAPK3—ovarian cancer	2.42e-05	0.00163	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—MAPK3—ovarian cancer	2.42e-05	0.00163	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MAPK3—ovarian cancer	2.41e-05	0.00162	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MAPK1—ovarian cancer	2.39e-05	0.00161	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—MAPK1—ovarian cancer	2.39e-05	0.00161	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—EGFR—ovarian cancer	2.39e-05	0.00161	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—EGFR—ovarian cancer	2.39e-05	0.00161	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—ERBB2—ovarian cancer	2.37e-05	0.00159	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—ERBB2—ovarian cancer	2.37e-05	0.00159	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—KRAS—ovarian cancer	2.35e-05	0.00158	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—CTNNB1—ovarian cancer	2.34e-05	0.00157	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—ERBB2—ovarian cancer	2.33e-05	0.00157	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MAPK1—ovarian cancer	2.3e-05	0.00155	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—MAPK1—ovarian cancer	2.3e-05	0.00155	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—EGFR—ovarian cancer	2.3e-05	0.00155	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—EGFR—ovarian cancer	2.3e-05	0.00155	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NME2—ovarian cancer	2.3e-05	0.00154	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MMP9—ovarian cancer	2.29e-05	0.00154	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MAPK1—ovarian cancer	2.29e-05	0.00154	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—EGFR—ovarian cancer	2.29e-05	0.00154	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MET—ovarian cancer	2.28e-05	0.00153	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	2.26e-05	0.00152	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—KRAS—ovarian cancer	2.26e-05	0.00152	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—KRAS—ovarian cancer	2.26e-05	0.00152	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—CTNNB1—ovarian cancer	2.24e-05	0.00151	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	2.23e-05	0.0015	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—IL6ST—ovarian cancer	2.23e-05	0.0015	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—ovarian cancer	2.23e-05	0.0015	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	2.22e-05	0.00149	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MMP9—ovarian cancer	2.19e-05	0.00148	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	2.19e-05	0.00147	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—KRAS—ovarian cancer	2.17e-05	0.00146	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—KRAS—ovarian cancer	2.17e-05	0.00146	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—KRAS—ovarian cancer	2.17e-05	0.00146	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—CTNNB1—ovarian cancer	2.15e-05	0.00145	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—CTNNB1—ovarian cancer	2.15e-05	0.00145	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MMP9—ovarian cancer	2.11e-05	0.00142	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MMP9—ovarian cancer	2.11e-05	0.00142	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—HRAS—ovarian cancer	2.09e-05	0.0014	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	2.08e-05	0.0014	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—CTNNB1—ovarian cancer	2.07e-05	0.00139	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—CTNNB1—ovarian cancer	2.07e-05	0.00139	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—VEGFA—ovarian cancer	2.06e-05	0.00139	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—STAT3—ovarian cancer	2.04e-05	0.00137	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	2.04e-05	0.00137	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	2.04e-05	0.00137	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	2.04e-05	0.00137	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—NRAS—ovarian cancer	2.03e-05	0.00137	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MMP9—ovarian cancer	2.03e-05	0.00137	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MMP9—ovarian cancer	2.03e-05	0.00137	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MMP9—ovarian cancer	2e-05	0.00135	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—IL6—ovarian cancer	2e-05	0.00134	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—HRAS—ovarian cancer	2e-05	0.00134	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—VEGFA—ovarian cancer	1.97e-05	0.00132	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—STAT3—ovarian cancer	1.95e-05	0.00131	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MAPK3—ovarian cancer	1.95e-05	0.00131	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—NRAS—ovarian cancer	1.95e-05	0.00131	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	1.92e-05	0.00129	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—HRAS—ovarian cancer	1.92e-05	0.00129	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—HRAS—ovarian cancer	1.92e-05	0.00129	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—IL6—ovarian cancer	1.91e-05	0.00128	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP2—ovarian cancer	1.9e-05	0.00128	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—VEGFA—ovarian cancer	1.89e-05	0.00127	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—VEGFA—ovarian cancer	1.89e-05	0.00127	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—STAT3—ovarian cancer	1.87e-05	0.00126	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—STAT3—ovarian cancer	1.87e-05	0.00126	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—NRAS—ovarian cancer	1.87e-05	0.00126	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—NRAS—ovarian cancer	1.87e-05	0.00126	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MAPK3—ovarian cancer	1.86e-05	0.00125	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MAPK1—ovarian cancer	1.85e-05	0.00125	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—EGFR—ovarian cancer	1.85e-05	0.00125	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—HRAS—ovarian cancer	1.85e-05	0.00124	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—HRAS—ovarian cancer	1.85e-05	0.00124	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—HRAS—ovarian cancer	1.84e-05	0.00124	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—IL6—ovarian cancer	1.83e-05	0.00123	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—IL6—ovarian cancer	1.83e-05	0.00123	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—VEGFA—ovarian cancer	1.83e-05	0.00123	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—VEGFA—ovarian cancer	1.83e-05	0.00123	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—STAT3—ovarian cancer	1.81e-05	0.00122	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—STAT3—ovarian cancer	1.81e-05	0.00122	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—NRAS—ovarian cancer	1.8e-05	0.00121	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—NRAS—ovarian cancer	1.8e-05	0.00121	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—VEGFA—ovarian cancer	1.8e-05	0.00121	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MAPK3—ovarian cancer	1.79e-05	0.0012	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MAPK3—ovarian cancer	1.79e-05	0.0012	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—NRAS—ovarian cancer	1.78e-05	0.00119	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MAPK1—ovarian cancer	1.77e-05	0.00119	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—EGFR—ovarian cancer	1.77e-05	0.00119	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—IL6—ovarian cancer	1.77e-05	0.00119	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—IL6—ovarian cancer	1.77e-05	0.00119	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—IL6—ovarian cancer	1.76e-05	0.00118	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—KRAS—ovarian cancer	1.75e-05	0.00118	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MAPK3—ovarian cancer	1.73e-05	0.00116	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MAPK3—ovarian cancer	1.73e-05	0.00116	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	1.71e-05	0.00115	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	1.71e-05	0.00115	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MAPK1—ovarian cancer	1.7e-05	0.00115	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MAPK1—ovarian cancer	1.7e-05	0.00115	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—EGFR—ovarian cancer	1.7e-05	0.00115	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—EGFR—ovarian cancer	1.7e-05	0.00115	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MAPK3—ovarian cancer	1.7e-05	0.00114	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	1.69e-05	0.00114	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—KRAS—ovarian cancer	1.67e-05	0.00113	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—ERBB2—ovarian cancer	1.67e-05	0.00112	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MAPK1—ovarian cancer	1.64e-05	0.0011	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MAPK1—ovarian cancer	1.64e-05	0.0011	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—EGFR—ovarian cancer	1.64e-05	0.0011	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—EGFR—ovarian cancer	1.64e-05	0.0011	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	1.63e-05	0.0011	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—AKT1—ovarian cancer	1.63e-05	0.00109	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MAPK1—ovarian cancer	1.62e-05	0.00109	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—EGFR—ovarian cancer	1.62e-05	0.00109	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—KRAS—ovarian cancer	1.61e-05	0.00108	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—KRAS—ovarian cancer	1.61e-05	0.00108	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NME2—ovarian cancer	1.6e-05	0.00107	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—KRAS—ovarian cancer	1.55e-05	0.00104	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—KRAS—ovarian cancer	1.55e-05	0.00104	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—KRAS—ovarian cancer	1.53e-05	0.00103	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—HRAS—ovarian cancer	1.49e-05	0.001	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYTB—ovarian cancer	1.48e-05	0.000995	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CTNNB1—ovarian cancer	1.46e-05	0.00098	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP9—ovarian cancer	1.43e-05	0.000961	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—IL6—ovarian cancer	1.42e-05	0.000958	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—HRAS—ovarian cancer	1.42e-05	0.000957	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—HRAS—ovarian cancer	1.37e-05	0.00092	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—HRAS—ovarian cancer	1.37e-05	0.00092	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—IL6—ovarian cancer	1.36e-05	0.000916	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NME2—ovarian cancer	1.35e-05	0.000909	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—HRAS—ovarian cancer	1.32e-05	0.000887	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—HRAS—ovarian cancer	1.32e-05	0.000887	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—AKT1—ovarian cancer	1.31e-05	0.000884	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—IL6—ovarian cancer	1.31e-05	0.00088	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—IL6—ovarian cancer	1.31e-05	0.00088	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—HRAS—ovarian cancer	1.3e-05	0.000874	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—BRIP1—ovarian cancer	1.29e-05	0.00087	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPP1CC—ovarian cancer	1.29e-05	0.00087	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—VEGFA—ovarian cancer	1.28e-05	0.000863	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—STAT3—ovarian cancer	1.27e-05	0.000854	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—NRAS—ovarian cancer	1.27e-05	0.000852	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—IL6—ovarian cancer	1.26e-05	0.000849	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—IL6—ovarian cancer	1.26e-05	0.000849	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—AKT1—ovarian cancer	1.26e-05	0.000845	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—IL6—ovarian cancer	1.24e-05	0.000836	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MAPK3—ovarian cancer	1.21e-05	0.000816	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—AKT1—ovarian cancer	1.21e-05	0.000812	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—AKT1—ovarian cancer	1.21e-05	0.000812	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—AKT1—ovarian cancer	1.16e-05	0.000783	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—AKT1—ovarian cancer	1.16e-05	0.000783	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MAPK1—ovarian cancer	1.15e-05	0.000777	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—EGFR—ovarian cancer	1.15e-05	0.000777	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.15e-05	0.000771	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—KRAS—ovarian cancer	1.09e-05	0.000734	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NME2—ovarian cancer	1.04e-05	0.000702	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYTB—ovarian cancer	1.03e-05	0.000692	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	9.35e-06	0.000629	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—HRAS—ovarian cancer	9.27e-06	0.000624	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPP1CC—ovarian cancer	8.99e-06	0.000605	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—BRIP1—ovarian cancer	8.99e-06	0.000605	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—IL6—ovarian cancer	8.87e-06	0.000597	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYTB—ovarian cancer	8.71e-06	0.000586	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—YAP1—ovarian cancer	8.68e-06	0.000583	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.52e-06	0.000573	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—AKT1—ovarian cancer	8.19e-06	0.000551	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPP1CC—ovarian cancer	7.62e-06	0.000512	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—BRIP1—ovarian cancer	7.62e-06	0.000512	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—FASN—ovarian cancer	7.07e-06	0.000476	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SLC5A5—ovarian cancer	6.96e-06	0.000468	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYTB—ovarian cancer	6.72e-06	0.000452	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SLC2A1—ovarian cancer	6.72e-06	0.000452	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP1B1—ovarian cancer	6.44e-06	0.000433	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—YAP1—ovarian cancer	6.03e-06	0.000406	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5.88e-06	0.000395	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—BRIP1—ovarian cancer	5.88e-06	0.000395	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	5.71e-06	0.000384	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.55e-06	0.000373	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ABCB1—ovarian cancer	5.3e-06	0.000357	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TYMS—ovarian cancer	5.21e-06	0.00035	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—YAP1—ovarian cancer	5.11e-06	0.000344	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.06e-06	0.00034	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—FASN—ovarian cancer	4.92e-06	0.000331	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	4.83e-06	0.000325	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	4.67e-06	0.000314	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	4.48e-06	0.000301	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.44e-06	0.000299	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CAV1—ovarian cancer	4.2e-06	0.000282	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—FASN—ovarian cancer	4.16e-06	0.00028	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SLC5A5—ovarian cancer	4.1e-06	0.000275	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	3.97e-06	0.000267	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SLC2A1—ovarian cancer	3.96e-06	0.000266	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—YAP1—ovarian cancer	3.94e-06	0.000265	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.87e-06	0.000261	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CG—ovarian cancer	3.82e-06	0.000257	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP1B1—ovarian cancer	3.79e-06	0.000255	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ABCB1—ovarian cancer	3.69e-06	0.000248	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TYMS—ovarian cancer	3.62e-06	0.000244	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	3.36e-06	0.000226	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CD—ovarian cancer	3.36e-06	0.000226	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.35e-06	0.000225	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—FASN—ovarian cancer	3.21e-06	0.000216	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.16e-06	0.000213	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.12e-06	0.00021	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TYMS—ovarian cancer	3.07e-06	0.000206	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.05e-06	0.000205	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CB—ovarian cancer	2.93e-06	0.000197	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.93e-06	0.000197	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CAV1—ovarian cancer	2.92e-06	0.000196	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	2.66e-06	0.000179	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.6e-06	0.000175	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTEN—ovarian cancer	2.53e-06	0.00017	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CAV1—ovarian cancer	2.47e-06	0.000166	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.41e-06	0.000162	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TYMS—ovarian cancer	2.37e-06	0.000159	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.36e-06	0.000159	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.34e-06	0.000157	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.25e-06	0.000151	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.04e-06	0.000137	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.98e-06	0.000133	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CAV1—ovarian cancer	1.91e-06	0.000128	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	1.79e-06	0.00012	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTEN—ovarian cancer	1.76e-06	0.000118	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.74e-06	0.000117	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.73e-06	0.000116	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.53e-06	0.000103	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTEN—ovarian cancer	1.49e-06	0.0001	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKT1—ovarian cancer	1.46e-06	9.81e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.33e-06	8.95e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.24e-06	8.35e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.15e-06	7.74e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.05e-06	7.07e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKT1—ovarian cancer	1.01e-06	6.82e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKT1—ovarian cancer	8.59e-07	5.78e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	8.12e-07	5.46e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKT1—ovarian cancer	6.63e-07	4.46e-05	CbGpPWpGaD
